Your browser doesn't support javascript.
loading
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples.
Trabucco, Sally E; Gowen, Kyle; Maund, Sophia L; Sanford, Eric; Fabrizio, David A; Hall, Michael J; Yakirevich, Evgeny; Gregg, Jeffrey P; Stephens, Phil J; Frampton, Garrett M; Hegde, Priti S; Miller, Vincent A; Ross, Jeffrey S; Hartmaier, Ryan J; Huang, Shih-Min A; Sun, James X.
Affiliation
  • Trabucco SE; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts. Electronic address: strabucco@foundationmedicine.com.
  • Gowen K; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Maund SL; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California.
  • Sanford E; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Fabrizio DA; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Hall MJ; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Yakirevich E; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  • Gregg JP; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts; Department of Pathology and Laboratory Medicine, UC Davis Health, Sacramento, California.
  • Stephens PJ; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Frampton GM; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Hegde PS; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California.
  • Miller VA; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Ross JS; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Hartmaier RJ; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Huang SA; Department of Oncology Biomarker Development, Genentech, Inc., San Francisco, California.
  • Sun JX; Department of Research and Development, Foundation Medicine, Inc., Cambridge, Massachusetts.
J Mol Diagn ; 21(6): 1053-1066, 2019 11.
Article in En | MEDLINE | ID: mdl-31445211
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microsatellite Instability / High-Throughput Nucleotide Sequencing / Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: J Mol Diagn Journal subject: BIOLOGIA MOLECULAR Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microsatellite Instability / High-Throughput Nucleotide Sequencing / Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: J Mol Diagn Journal subject: BIOLOGIA MOLECULAR Year: 2019 Type: Article